Monte Rosa Therapeutics, Inc. (GLUE)
NASDAQ: GLUE · Real-Time Price · USD
9.37
+0.06 (0.64%)
At close: Nov 13, 2026, 4:00 PM EST
9.50
+0.13 (1.39%)
After-hours: Nov 13, 2026, 7:30 PM EST
Monte Rosa Therapeutics Market Cap
Monte Rosa Therapeutics has a market cap or net worth of $800.67 million as of November 13, 2026. It is the 11,286th most valuable company in the world and the 2,376th biggest in the United States. Its market cap has decreased by 13.17% in one year.
Market Cap
800.67M
Enterprise Value
259.21M
1-Year Change
-13.17%
Global Rank
Country Rank
#2,376 United States
Category
ChartMarket Cap Chart
Since the IPO on June 24, 2021, Monte Rosa Therapeutics's market cap has decreased from $845.31M to $800.67M, a decrease of -5.28%. That is a compound annual growth rate of -1.00%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 800.67M | -21.58% |
| Dec 31, 2025 | 1.02B | 139.48% |
| Dec 31, 2024 | 426.37M | 50.74% |
| Dec 29, 2023 | 282.85M | -23.21% |
| Dec 30, 2022 | 368.32M | -61.22% |
| Dec 31, 2021 | 949.65M | 12.34% |
| Jun 24, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Syndax Pharmaceuticals | 857.07M |
| Latigo Biotherapeutics | 851.28M |
| MeiraGTx Holdings | 849.98M |
| Bambusa Therapeutics | 848.45M |
| Alumis | 810.91M |
| Lexicon Pharmaceuticals | 810.33M |
| Ardelyx | 781.77M |
| Solid Biosciences | 780.16M |